199 related articles for article (PubMed ID: 23520498)
1. Detection of drug-drug interactions by modeling interaction profile fingerprints.
Vilar S; Uriarte E; Santana L; Tatonetti NP; Friedman C
PLoS One; 2013; 8(3):e58321. PubMed ID: 23520498
[TBL] [Abstract][Full Text] [Related]
2. State of the art and development of a drug-drug interaction large scale predictor based on 3D pharmacophoric similarity.
Vilar S; Uriarte E; Santana L; Friedman C; Tatonetti NP
Curr Drug Metab; 2014; 15(5):490-501. PubMed ID: 25431152
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interaction through molecular structure similarity analysis.
Vilar S; Harpaz R; Uriarte E; Santana L; Rabadan R; Friedman C
J Am Med Inform Assoc; 2012; 19(6):1066-74. PubMed ID: 22647690
[TBL] [Abstract][Full Text] [Related]
4. Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.
Hameed PN; Verspoor K; Kusljic S; Halgamuge S
BMC Bioinformatics; 2017 Mar; 18(1):140. PubMed ID: 28249566
[TBL] [Abstract][Full Text] [Related]
5. SubGE-DDI: A new prediction model for drug-drug interaction established through biomedical texts and drug-pairs knowledge subgraph enhancement.
Shi Y; He M; Chen J; Han F; Cai Y
PLoS Comput Biol; 2024 Apr; 20(4):e1011989. PubMed ID: 38626249
[TBL] [Abstract][Full Text] [Related]
6. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interaction discovery and demystification using Semantic Web technologies.
Noor A; Assiri A; Ayvaz S; Clark C; Dumontier M
J Am Med Inform Assoc; 2017 May; 24(3):556-564. PubMed ID: 28031284
[TBL] [Abstract][Full Text] [Related]
8. Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.
Song D; Chen Y; Min Q; Sun Q; Ye K; Zhou C; Yuan S; Sun Z; Liao J
J Clin Pharm Ther; 2019 Apr; 44(2):268-275. PubMed ID: 30565313
[TBL] [Abstract][Full Text] [Related]
9. Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling.
Vilar S; Lorberbaum T; Hripcsak G; Tatonetti NP
PLoS One; 2015; 10(6):e0129974. PubMed ID: 26068584
[TBL] [Abstract][Full Text] [Related]
10. Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis.
Hecker M; Frahm N; Zettl UK
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38276481
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Drug-Drug Interactions by Using Profile Fingerprint Vectors and Protein Similarities.
Dere S; Ayvaz S
Healthc Inform Res; 2020 Jan; 26(1):42-49. PubMed ID: 32082699
[TBL] [Abstract][Full Text] [Related]
12. Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models.
Yamada M; Inoue SI; Sugiyama D; Nishiya Y; Ishizuka T; Watanabe A; Watanabe K; Yamashita S; Watanabe N
Drug Metab Dispos; 2020 Apr; 48(4):288-296. PubMed ID: 31996361
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
Tavassoli N; Sommet A; Lapeyre-Mestre M; Bagheri H; Montrastruc JL
Drug Saf; 2007; 30(11):1063-71. PubMed ID: 17973542
[TBL] [Abstract][Full Text] [Related]
14. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.
Cheng F; Zhao Z
J Am Med Inform Assoc; 2014 Oct; 21(e2):e278-86. PubMed ID: 24644270
[TBL] [Abstract][Full Text] [Related]
15. Similarity-based modeling in large-scale prediction of drug-drug interactions.
Vilar S; Uriarte E; Santana L; Lorberbaum T; Hripcsak G; Friedman C; Tatonetti NP
Nat Protoc; 2014 Sep; 9(9):2147-63. PubMed ID: 25122524
[TBL] [Abstract][Full Text] [Related]
16. The DDI corpus: an annotated corpus with pharmacological substances and drug-drug interactions.
Herrero-Zazo M; Segura-Bedmar I; Martínez P; Declerck T
J Biomed Inform; 2013 Oct; 46(5):914-20. PubMed ID: 23906817
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of frequently used drug interaction screening programs.
Vonbach P; Dubied A; Krähenbühl S; Beer JH
Pharm World Sci; 2008 Aug; 30(4):367-74. PubMed ID: 18415695
[TBL] [Abstract][Full Text] [Related]
18. QSAR Modeling and Prediction of Drug-Drug Interactions.
Zakharov AV; Varlamova EV; Lagunin AA; Dmitriev AV; Muratov EN; Fourches D; Kuz'min VE; Poroikov VV; Tropsha A; Nicklaus MC
Mol Pharm; 2016 Feb; 13(2):545-56. PubMed ID: 26669717
[TBL] [Abstract][Full Text] [Related]
19. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity of drug interaction databases to detect interactions with recently approved oral antineoplastics.
Bossaer JB; Eskens D; Gardner A
J Oncol Pharm Pract; 2022 Jan; 28(1):82-86. PubMed ID: 33435823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
